An oncolytic virus for melanoma tumors with defective interferon signaling, designed as a potent, specific and safe therapy. Promising in-vivo murine melanoma model shows potential for development as a mono or an add-on to chemotherapy or check-point inhibitorsUNMET NEEDOn Nov. 2015 the FDA ...
Scientific Contact:
Marcelo EHRLICH
1586128566.jpg)